TP53 and neoplasm: CDK2 is a key kinase in the G1 phase of the cell cycle, and inhibition of CDK2 leads to cell cycle arrest, whereas MDM2 and p53 have effects on apoptosis, cell cycle arrest, cellular senescence, and autophagy in tumor cells [16].